MediPharm Labs Corp (MEDIF)
0.0536
0.00 (0.00%)
USD |
OTCM |
Jun 14, 16:00
MediPharm Labs Total Assets (Quarterly): 45.33M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 45.33M |
| December 31, 2023 | 48.20M |
| September 30, 2023 | 50.03M |
| June 30, 2023 | 55.48M |
| March 31, 2023 | 45.88M |
| December 31, 2022 | 48.26M |
| September 30, 2022 | 52.09M |
| June 30, 2022 | 61.50M |
| March 31, 2022 | 67.75M |
| December 31, 2021 | 72.44M |
| September 30, 2021 | 92.67M |
| June 30, 2021 | 103.38M |
| March 31, 2021 | 108.79M |
| Date | Value |
|---|---|
| December 31, 2020 | 92.72M |
| September 30, 2020 | 112.23M |
| June 30, 2020 | 130.89M |
| March 31, 2020 | 101.38M |
| December 31, 2019 | 129.25M |
| September 30, 2019 | 138.26M |
| June 30, 2019 | 132.78M |
| March 31, 2019 | 52.53M |
| September 30, 2018 | 0.3568M |
| June 30, 2018 | 0.3839M |
| March 31, 2018 | 0.4069M |
| December 31, 2017 | 0.3055M |
| September 30, 2017 | 0.3216M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
45.33M
Minimum
Mar 2024
138.26M
Maximum
Sep 2019
84.46M
Average
82.55M
Median
Total Assets (Quarterly) Benchmarks
| Venus Concept Inc | 85.08M |
| Acasti Pharma Inc | 76.18M |
| Aurinia Pharmaceuticals Inc | 548.06M |
| Edesa Biotech Inc | 6.475M |
| Lexaria Bioscience Corp | 6.352M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 8.430M |
| Shareholders Equity (Quarterly) | 36.90M |
| Debt to Equity Ratio | 0.0397 |
| Current Ratio | 3.069 |
| Net Debt Paydown Yield | -0.84% |